Prescription-Drug-Spending_Regence

Why we're addressing the growth in medication spending

By Regence | June 16, 2015

Prescription drug costs are making headlines nationwide, from the Wall Street Journal to your local business journal. Historically, we have guided our members to generic versions for cost relief. But relief is getting hard to find.

A snapshot of specialty drug costs shows why. Drawing on data from affiliated plans across the country, the Blue Cross and Blue Shield Association’s “The Health of America” report shows specialty drugs are driving the growth in medication spending. For these drugs, there are no low-cost options.

Specialty drugs for conditions like multiple sclerosis, rheumatoid arthritis, psoriasis and hepatitis C now comprise 23% of all prescription spending – and that segment rose 20% last year.

When there’s only one of a drug, we have limited bargaining power on price. But as Blue plans, together we can use our influence to shift the places they are administered to lower-cost venues.

That’s just one way we advocate for our members to make health costs more affordable and sustainable.

Learn more about The Health of America.

Share:

Recent posts

FB_6

Promoting safe prescription drug disposal with National Drug Take-Back Day

By Regence
April 28, 2017
National Prescription Drug Take-Back Day provides the public with a safe, convenient and responsible way to dispose of unwanted and expired medications at no cost.
TEDxPortland-colin

Shining a light on Oregon innovation

By Andrew Over
April 27, 2017
Regence is committed to building strong, equitable and vibrant communities. We are grateful to partner with organizations like TEDxPortland who encourage the same innovative, people-focused spirit.
regence-virginia-garcia-partnership

Regence partners with Virginia Garcia to support women and children’s health

By Regence
April 25, 2017
Recently one of the organizations that Regence supports, the Virginia Garcia Memorial Health Center, hosted its 9th Annual Health Care Symposium: Women & Children First.